It is estimated 1 million patients worldwide are treated with Acunova each month
Acunova is an acupuncture protocol, invented by Dr. John Boel, that is showing measurable results in treating macular degeneration and other eye diseases.
Needles are NEVER placed in the eyes.
Research shows 80% of patients experience vision improvement. The 20% that do not see improvement still showed NO DETERIORATION at the 6 month mark after treatment.
See impressive case studies below.
Acunova can be used for the following diagnoses:
- Wet & Dry macular degeneration
- Juvenile macular degeneration (Stargardt disease)
- Age-related macular degeneration
- Retinal degeneration
- Far-sightedness (presbyopia)
- Diabetic Retinopathy
- Optic atrophy
- Retinopathy Pigmentosa / Retinitis Pigmentosa
- Photoreceptor atrophy
- Retinal pigment epithelium shift
- Autoimmune related vision loss
- Post-stroke vision loss
After Acunova treatments patients report the following improvements:
“Improvement in the ability to read and write”
“Improvement of vision and the ability to see at close range and distance”
“Improvement of the ability to perceive colors”
“Regained the ability to drive”
“Enlargement of the field of vision”
“Improvement of night vision”
“Improvement of general health and immune system”
“The dissolution of water bubbles”
“Relaxation of the muscles of the forehead and eyes”
Acunova is a new system of acupuncture, particularly beneficial for the eyes. It was developed by Denmark doctor and acupuncturist, Dr. John Boel in the late 1990’s. He has since been elected “Acupuncturist of the Century” by an International Congress of Complementary Medicine.
Acunova is based on a microsystem of the hand. Its points are situated near specific joints. From these points signals are sent to the brain to influence healing of the ocular system.
Years of research by Dr. Boel, his trainees, and scientists yielded astounding results. Most research shows 80% of patients experience vision improvement. Most of these patients see an improvement of 15-40%, some even higher. The 20% that do not see improvement still showed NO DETERIORATION at the 6 month mark after treatment.
Many years of practice show that almost all eye diseases are successfully treatable. At Boel Acupuncture in Denmark, about 750 treatments are performed each week in four clinics. The success rate statistics document the following results of treatments with the following eye diseases (these are the percentages of patients that experience improvement):
Dry and Wet Macular Degeneration (ARMD) – 83%
Blindness due to brain disorders – 82%
Glaucoma / Green Star – 81%
Retinitis Pigmentosa – 80%
Eye diseases caused by diabetes – 79%
Other eye diseases – on average 80%
Dr. Hans Peter Wutta of Germany published a book on his scientific studies using Dr. Boel’s Acunova protocol. His results showed 76% of patients improved with Acunova. Dr. Wutta’s studies with Boel’s protocol showed age did not impact the results. Also, that wet & dry macular degeneration had identical treatment results.
Here are some examples of his case studies of patients diagnosed with “Incurable” eye diseases according to medical science.
-Daniella, Austria (29): Completely blind due to excessive oxygen supply while in the incubator. After a week of Acunova treatment, she could see a little for the first time. After six weeks of treatment, she no longer needed a guide dog because she could walk alone. Today she works full time.
-Annika (12): Juvenile macular degeneration. 20% eyesight before acunova treatment. 100% eyesight after one year.
-Claus, Norway (13): tunnel vision (retinitis pigmentosa). Only 1% vision in the right eye, completely blind in the left eye. After one year of acunova treatment, he achieved 50% vision in both eyes. Claus is the first retinitis pigmentosa patient in the world whose eyes have been healed. He became the youngest judge in Norway.
-Thorgun (23): Completely blind for 10 years after a traffic accident.
About 80% vision after 9 weeks of acunova treatment.
There is more research to be done and Dr. Siegel will be keeping track of case studies and statistics. She will move forward to work with eye care specialists for further research. If you are interested in collaborating please contact us.
It is estimated that 250,000 patients are treated worldwide using Acunova each week. We would like to increase that number by adding this service here in the southeast USA.
No negative side effects of the Acunova protocol have been reported.
Complimentary consultations are available.
Cost: $270 per treatment day (2 treatments in 2 hours)